Home
Conditions
Small Cell Lung Cancer Extensive Stage

Clinical trial condition

Small Cell Lung Cancer Extensive Stage

Explore clinical trials studying Small Cell Lung Cancer Extensive Stage. Study availability and eligibility vary by location and protocol.

29 public trials 13 recruiting studies

Refine in advanced search Browse all conditions

Small Cell Lung Cancer Extensive Stage trial results

Recruiting

Liposomal Irinotecan and Apatinib in ES-SCLC

NCT06749691

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations: Second Affiliated Hospital of Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Irinotecan Liposome (II) or Etoposide Combined With Adebrelimab and Carboplatin in the Treatment of ES-SCLC

NCT06739928

Conditions: Small Cell Lung Cancer Extensive Stage
Locations: Guangzhou Institute of Respiratory Disease (Responsible Party) Guangzhou, China

View Trial Details

Recruiting

Molecular Analysis and Treatment Options of SCLC

NCT05945745

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +11 more
Locations: Shanghai Chest Hospital Shanghai, China

View Trial Details

Not Yet Recruiting

BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)

NCT07625644

Conditions: Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +19 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

DSP-0390 in Combination With Atezolizumab for Small Cell Lung Cancer

NCT07545954

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +9 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Not Yet Recruiting

A Retrospective Real-World Study on the Efficacy and Safety of Anlotinib Hydrochloride Combined With Immunotherapy Maintenance Therapy Following Standard Chemoimmunotherapy for ES-SCLC (ALTER-L059)

NCT06982287

Conditions: Small Cell Lung Cancer Extensive Stage
Locations: Not specified

View Trial Details

Not Yet Recruiting

Sintilimab Plus Anlotinib as Second or Further-line Therapy for ES-SCLC Who Have Progressed After Anti-PD-1/L1 Therapy

NCT07022301

Conditions: Resistance to Immunotherapy, Small Cell Lung Cancer Extensive Stage
Locations: Not specified

View Trial Details

Not Yet Recruiting

Tislelizumab in Combination with Chemotherapy ± Radiotherapy for Extensive-Stage Oligometastatic Small Cell Lung Cancer.

NCT06851819

Conditions: Small Cell Lung Cancer Extensive Stage
Locations: Hebei Medical University Fourth Hospital Shijiazhuang, Hebei, China

View Trial Details

Not Yet Recruiting

Etoposide Plus Benmelstobart Followed by Maintenance Therapy of Benmelstobart Plus Anlotinib in First-line Treatment of Elderly Patients with Extensive Stage Small Cell Lung Cancer: a Single-arm, Prospective Trial

NCT06825208

Conditions: Elderly People, Small Cell Lung Cancer Extensive Stage
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Single-arm, Multicenter, Prospective Phase II Clinical Study of Apatinib in Combination With Adebrelimab and EC Regimen in the First-line Treatment of Extensive Small Cell Lung Cancer

NCT06786312

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations: Fujian Cancer Hospital Fuzhou, Fujian, China

Fujian Provincial Hospital Fuzhou, Fujian, China

The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China

The First Affiliated Hospital of Fujian Medical University Fuzhou, China

View Trial Details

Small Cell Lung Cancer Extensive Stage

Small Cell Lung Cancer Extensive Stage trial results

Related conditions